About a quarter of Americans suffer hardening of the valves by age 65 and about half by 85. Without a suitable drug, the only treatment is surgical replacement.
Sales of the essential oil copaiba [koh-pey-buh] are increasing, at least in part, because more than 54 million Americans suffer from arthritis. The traditional way to treat arthritis is using NSAIDs and COXIBs, which are not without adverse events. For arthritis sufferers, copaiba may turn out to be a silver bullet or, perhaps, snake oil.
In a survey of adults with anxiety or a mood disorder like depression or bipolar disorder, about half reported experiencing chronic pain, according to researchers.
Stepping up to biologic therapy when methotrexate monotherapy fails offers minimal incremental benefit over using a combination of drugs known as triple therapy, yet incurs large costs for treating rheumatoid arthritis (RA), research concludes.
Patients with psoriatic arthritis for whom standard-of-care pharmaceutical treatments have provided no lasting relief experienced a significant reduction in symptoms, including joint tenderness and swelling, have reported promising results when they were given a new drug.
A new device gently suctions, processes and uses a patient’s own fat tissue to provide a potential source of stem cells and growth factors to promote healing.
Osteoarthritis can potentially be prevented with a good diet and regular exercise, a new expert review reports.
Using CRISPR technology, a team of researchers rewired stem cells’ genetic circuits to produce an anti-inflammatory arthritis drug when the cells encounter inflammation. The technique eventually could act as a vaccine for arthritis and other chronic conditions.
A drug combination that could help thousands of children with arthritis has been discovered by a team of researchers. Children and adolescents with Juvenile Idiopathic Arthritis (JIA) are likely to develop uveitis, a condition that causes inflammation in the middle layer of the eye. The drug combination discovery will help preventing them from serious complications, including blindness.
Throughout the course of a leprosy infection, patients often have episodes of painful inflammation affecting their skin and nerves. Researchers have continuously struggled with finding effective drugs to treat these so-called ‘type 1 reactions,’ and now one more study has come up empty-handed. The immune-suppressant azathioprine did not improve the standard of care treatment with steroids, researchers report.